Circulating angiogenic and antiangiogenic factors in women with eclampsia.
about
First trimester uterine artery Doppler for the prediction of preeclampsia and foetal growth restriction.In vivo experiments reveal the good, the bad and the ugly faces of sFlt-1 in pregnancy.Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease.Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice.The adaptation of the blood-brain barrier to vascular endothelial growth factor and placental growth factor during pregnancyThe Impact of Magnesium Sulfate Therapy on Angiogenic Factors in Preeclampsia.Vascular Endothelial Growth Factor and Podocyte Protection in Chronic Hypoxia: Effects of Endothelin-A Receptor Antagonism.High viral load and elevated angiogenic markers associated with increased risk of preeclampsia among women initiating highly active antiretroviral therapy in pregnancy in the Mma Bana study, Botswana.Innate Immune System at the Maternal-Fetal Interface: Mechanisms of Disease and Targets of Therapy in Pregnancy Syndromes.Vitamin D reverses aPL-induced inflammation and LMWH-induced sFlt-1 release by human trophoblast.Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity.Failure of physiologic transformation of spiral arteries, endothelial and trophoblast cell activation, and acute atherosis in the basal plate of the placenta.Associations between insulin-like growth factor I, vascular endothelial growth factor and its soluble receptor 1 in umbilical serum and endothelial cells obtained from normotensive and preeclamptic pregnancies.Soluble VEGFR-1 in pathophysiology of pregnancies complicated by hypertensive disorders: the Indian scenario.Placental Growth Factor as a Prognostic Tool in Women With Hypertensive Disorders of Pregnancy: A Systematic Review.The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio).Is an episode of suspected preterm labor that subsequently leads to a term delivery benign?Genetic predisposition to preeclampsia is conferred by fetal DNA variants near FLT1, a gene involved in the regulation of angiogenesis.Placental C4d deposition is a feature of defective placentation: observations in cases of preeclampsia and miscarriage.Expression of antiangiogenic factors in the placental structures in pre-eclampsia.Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia
P2860
Q33955769-F9AA7E75-F522-4646-874B-EA035C0D8340Q34505704-C4DF2F49-4FBD-4541-8446-D83F0216A802Q35143007-153398B3-1236-4FA4-BF09-E416F8CF2B8AQ35362708-B03BFAE0-E11E-476B-83ED-8B78CD338068Q35647966-78AE26F9-E0A9-43F4-BC21-119C7E781297Q35661796-36419B50-BF64-410E-9387-16F06512DD8AQ36788592-5873A586-A527-4F19-B995-C25D4A3D3B2BQ36930454-49E7719D-0BA7-400C-AFEA-2A81D2437F4DQ38816011-B9C17CE0-0F3A-44F2-BA19-F465C5515FA5Q38970808-71922B31-FBBD-41E5-AADF-58DE3C2B5126Q39376655-E311DEE4-8AF1-4FAA-B8AA-0C1456866092Q40402667-56BE4764-C6E2-4B62-9A69-9006A443C15EQ42439680-08B00343-1998-447E-862E-9695CF389E9DQ45831979-012FC038-4B9C-4700-B5E9-DB7B9DD0F07AQ47154280-B7B13CA1-5DFB-4CCA-B45D-AA959E1010A5Q47645647-B9DDEE62-0D89-4D5E-85CB-0B48B572C825Q49243157-354A66F5-D92E-4547-B7D8-E85723DF3831Q50017347-DB7BAA21-8CDF-4877-A622-9BF58FA61384Q53565891-30F13918-4663-49C5-BF7F-3F81589E9A7EQ54456305-8EF15C79-068B-4B28-815F-7D19B8111492Q58795465-F606D6F3-A442-44C0-866B-49C81E987C27
P2860
Circulating angiogenic and antiangiogenic factors in women with eclampsia.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Circulating angiogenic and antiangiogenic factors in women with eclampsia.
@ast
Circulating angiogenic and antiangiogenic factors in women with eclampsia.
@en
Circulating angiogenic and antiangiogenic factors in women with eclampsia.
@nl
type
label
Circulating angiogenic and antiangiogenic factors in women with eclampsia.
@ast
Circulating angiogenic and antiangiogenic factors in women with eclampsia.
@en
Circulating angiogenic and antiangiogenic factors in women with eclampsia.
@nl
prefLabel
Circulating angiogenic and antiangiogenic factors in women with eclampsia.
@ast
Circulating angiogenic and antiangiogenic factors in women with eclampsia.
@en
Circulating angiogenic and antiangiogenic factors in women with eclampsia.
@nl
P2093
P2860
P50
P1476
Circulating angiogenic and antiangiogenic factors in women with eclampsia.
@en
P2093
David B Cotton
Janice E Whitty
Juan Pedro Kusanovic
Sonia S Hassan
P2860
P304
P356
10.1016/J.AJOG.2010.08.049
P407
P577
2010-11-09T00:00:00Z